Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 11/20 | 0.55 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31191628 | 1.00 | ALOX5 (0.55) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| SCHEMBL30530994 | 1.00 | ALOX5 (0.55) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| SCHEMBL28571843 | 0.98 | ALOX5 (0.53) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| Hydrochloric Acid SCHEMBL31235549 | 0.98 | ALOX5 (0.53) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| SCHEMBL3421834 | 0.92 | ALOX5 (0.50) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| Xanthene SCHEMBL4193453 | 0.89 | MAOA (0.49) | ALOX5DHODHCYP1A2CYP2C19TAAR1 | |
| Nitric Acid SCHEMBL997582 | 0.88 | ALOX5 (0.47) | ALOX5ALDH1A1GAAKDM4E | |
| SCHEMBL18162295 | 0.81 | TAAR1 (0.41) | CYP1A2CYP2C19TAAR1HSD17B10ALDH1A1 | |
| SCHEMBL3894760 | 0.78 | CYP1A2 (0.35) | ALOX5CYP1A2CYP2C19TAAR1ALDH1A1 | |
| SCHEMBL19971565 | 0.77 | ALOX5 (0.44) | ALOX5DHODHALDH1A1TDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1741 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695308-A1 | ENGINEERED ANTIBODIES AND USES THEREOF | Invitrogen BioServices India Private Limited (IN) | 2026-02-18 | — | — | EP | claimed |
| EP-4687982-A1 | METHOD FOR INDUCING TUMOR REGRESSION | VeroScience LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2025262706-A1 | SITE-SPECIFIC PROTEIN LABELING USING OLIGONUCLEOTIDE TAGS | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED (IN) | 2025-12-26 | — | — | WO | claimed |
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | FREISTAAT BAYERN LUDWIG MAXIMILIANS UNIV MUENCHEN (DE) | 2025-12-11 | — | — | US | claimed |
| US-12318451-B2 | Method for inducing tumor regression | VEROSCIENCE LLC (US) | 2025-06-03 | — | — | US | claimed |
| EP-3419542-B1 | METHOD AND APPARATUS FOR TIGHTENING SKIN | MASSACHUSETTS GEN HOSPITAL (US) | 2025-05-14 | — | — | EP | claimed |
| US-20250143865-A1 | METHODS AND SYSTEMS FOR PREVENTING OR REDUCING STENOSIS IN A SUBJECT RECEIVING A GRAFT | MASSACHUSETTS GEN HOSPITAL (US) | 2025-05-08 | — | — | US | claimed |
| US-20250121118-A1 | SYSTEMS, APPARATUSES, KITS, AND METHODS FOR MODIFICATION OF TISSUE USING A PHOTO-INITIATOR AND LIGHT | DURVENA INC (US) | 2025-04-17 | — | — | US | claimed |
| US-12269909-B2 | Polymer composition and a method of preparing a polymer resin | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-04-08 | — | — | US | claimed |
| WO-2025057225-A1 | ENGINEERED ANTIBODIES AND USES THEREOF | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED (IN) | 2025-03-20 | — | — | WO | claimed |
| EP-0910365-A1 | GROWTH INHIBITION AND ERADICATION OF SOLID TUMORS USING NEUROENDOCRINE RESETTING THERAPY AND PHOTODYNAMIC THERAPY | Ergo Research Corporation (US) | 1999-04-28 | — | — | EP | claimed |
| EP-0885263-A1 | BENZOPHENOXAZINE DYES | Amersham Pharmacia Biotech UK Limited (GB) | 1998-12-23 | — | — | EP | claimed |
| US-5832931-A | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents | PHOTOGEN, INC. (US) | 1998-11-10 | — | — | US | claimed |
| US-5831144-A | Refrigeration compressor oil testing process and apparatus | PASTORELLO JOHN (US) | 1998-11-03 | — | — | US | claimed |
| WO-1997040829-A9 | GROWTH INHIBITION AND ERADICATION OF SOLID TUMORS USING NEUROENDOCRINE RESETTING THERAPY AND PHOTODYNAMIC THERAPY | — | 1998-01-22 | — | — | WO | claimed |
| WO-1997040829-A1 | GROWTH INHIBITION AND ERADICATION OF SOLID TUMORS USING NEUROENDOCRINE RESETTING THERAPY AND PHOTODYNAMIC THERAPY | ERGO RESEARCH CORPORATION (US) | 1997-11-06 | — | — | WO | claimed |
| WO-1997029154-A1 | BENZOPHENOXAZINE DYES | AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) | 1997-08-14 | — | — | WO | claimed |
| WO-1997026885-A1 | BENZOPHENOTHIAZINE AND BENZOPORPHYRIN DYE COMBINATION PHOTODYNAMIC THERAPY OF TUMORS | THE GENERAL HOSPITAL CORPORATION DOING BUSINESS AS MASSACHUSETTS GENERAL HOSPITAL (US) | 1997-07-31 | — | — | WO | claimed |
| US-3997541-A | Lactones of the benzazaxanthene series and dye-forming components for duplication processes | BASF AKTIENGESELLSCHAFT (DT) | 1976-12-14 | — | — | US | claimed |
| US-3946017-A | PRESSURE SENSITIVE MATERIALS | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CRY1, MKI67, IK | ALOX5 1864/4885DHODH 42/4885CYP1A2 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.